SILO PHARMA, INC. Stock Issued During Period, Shares, Restricted Stock Award, Gross
SILO PHARMA, INC. (SILO) reported Stock Issued During Period, Shares, Restricted Stock Award, Gross of 20.00 thousand shares for the 1-month period ending 2022-08-29, per its 10-K filed 2023-03-24.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2025-03-28
- 2022-08-29: Stock Issued During Period, Shares, Restricted Stock Award, Gross 20.00K shares; Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month 20.00K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month |
|---|---|---|
| 2022-08-29 | 20.00K shares 10-K · filed 2025-03-28 | 20.00K shares 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |